PALB2 and breast cancer: We, thus, assessed the methylation status of five genes (ATM, BRCA1, PALB2, RAD51B, and XRCC3) involved in HRR (which is deficient in a large proportion of male BC cases) looking for biomarkers that might be useful for clinical management.